VENLO, THE NETHERLANDS--(Marketwire - August 04, 2008) - New cervical cancer prevention guidelines issued by the German Association for Gynecology and Obstetrics (DGGG) recommend testing women 30 and over for HPV (human papillomavirus) -- the primary cause of cervical cancer. The guidelines recommend that HPV testing be performed along with a Pap smear for women 30 and older. The digene® HPV Test, developed by QIAGEN (NASDAQ: QGEN) (Frankfurt, Prime Standard: QIA), is currently the only HPV test approved by regulatory authorities in both Europe and the United States.
